References

Phosphorus NMR studies on perfused heart

10.1016/0006-291x(77)91653-9 · 1977 · External reference

NMR Spectroscopy of the human heart

2009 · External reference

Metabolic imaging of the human heart: clinical application of magnetic resonance spectroscopy

10.1136/heartjnl-2012-302546 · 2014 · External reference

MRS: a noninvasive window into cardiac metabolism

10.1002/nbm.3320 · 2015 · External reference

Clinical cardiac magnetic resonance spectroscopy

10.1016/j.pcad.2011.08.002 · 2011 · External reference

Magnetic resonance spectroscopy in myocardial disease

10.1016/j.jcmg.2008.08.005 · 2009 · External reference

Unresolved reference

2002 · External reference

Unresolved reference

1995 · External reference

Unresolved reference

2007 · External reference

Unresolved reference

2000 · External reference

Terminology and concepts for the characterization of in vivo MR spectroscopy methods and MR spectra: background and experts’ consensus recommendations

2020 · External reference

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

10.1006/jmre.1997.1244 · 1997 · External reference

OXSA: An open-source magnetic resonance spectroscopy analysis toolbox in MATLAB

10.1371/journal.pone.0185356 · 2017 · External reference

Estimation of metabolite concentrations from localized in-Vivo Proton NMR-Spectra

10.1002/mrm.1910300604 · 1993 · External reference

Unresolved reference

2008 · External reference

Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections

10.1002/nbm.2961 · 2013 · External reference

Feasibility of absolute quantification for (31) P MRS at 7 T

10.1002/mrm.27729 · 2019 · External reference

Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles

1982 · External reference

Transport of energy in muscle: the phosphorylcreatine shuttle

10.1126/science.6450446 · 1981 · External reference

Fluxes through cytosolic and mitochondrial creatine kinase, measured by P-31 NMR

10.1023/a:1006847605088 · 1997 · External reference

The creatine-phosphocreatine system: there’s more than one song in its repertoire

10.1113/jphysiol.2001.013478 · 2001 · External reference

Cardiac magnetic resonance spectroscopy

2003 · External reference

In vivo assessment of free magnesium concentration in human brain by P-31 MRS. A new calibration curve based on a mathematical algorithm

10.1002/(sici)1099-1492(199602)9:1<24::aid-nbm392>3.0.co;2-b · 1996 · External reference

In vivo P-31-MRS assessment of cytosolic [Mg2+] in the human skeletal muscle in different metabolic conditions

10.1016/s0730-725x(00)00132-6 · 2000 · External reference

Relation between work and phosphate metabolite in the in vivo paced mammalian heart

10.1126/science.3704638 · 1986 · External reference

Transmural bioenergetic responses of normal myocardium to high workstates

1995 · External reference

Roles of the creatine kinase system and myoglobin in maintaining energetic state in the working heart

10.1186/1752-0509-3-22 · 2009 · External reference

Systems level regulation of cardiac energy fluxes via metabolic cycles: role of creatine, phosphotransfer pathways, and AMPK signaling

10.1007/978-3-642-38505-6_11 · 2014 · External reference

On the theoretical limits of detecting cyclic changes in cardiac high-energy phosphates and creatine kinase reaction kinetics using in vivo P-31 MRS

10.1002/nbm.3302 · 2015 · External reference

Temporal relation between energy-metabolism and myocardial-function during ischemia and reperfusion

1987 · External reference

Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction

10.1172/jci117756 · 1995 · External reference

Triple repetition time saturation transfer (TRiST) P-31 spectroscopy for measuring human creatine kinase reaction kinetics

10.1002/mrm.22347 · 2010 · External reference

Unresolved reference

External reference

In-vivo(31)P-MRS of skeletal muscle and liver: a way for non-invasive assessment of their metabolism

10.1016/j.ab.2017.01.018 · 2017 · External reference

High resolution proton NMR studies of perfused rat hearts

10.1016/0014-5793(84)80835-2 · 1984 · External reference

1H NMR measurement of triacylglycerol accumulation in the post-ischemic canine heart after transient increase of plasma lipids

10.1006/jmcc.1996.9997 · 1997 · External reference

Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium

10.1148/radiology.219.2.r01ma39411 · 2001 · External reference

Reduced (1)H-NMR visibility of creatine in isolated rat hearts

10.1002/(sici)1522-2594(200004)43:4<497::aid-mrm2>3.0.co;2-m · 2000 · External reference

Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium

10.1016/s0140-6736(97)06402-7 · 1998 · External reference

Water-suppression cycling 3-T cardiac (1) H-MRS detects altered creatine and choline in patients with aortic or mitral stenosis

10.1002/nbm.4513 · 2021 · External reference

Metabolic MR imaging of regional triglyceride and creatine content in the human heart

10.1002/mrm.24178 · 2012 · External reference

A technique for in vivo mapping of myocardial creatine kinase metabolism

10.1038/nm.3436 · 2014 · External reference

ATP flux through creatine kinase in the normal, stressed, and failing human heart

10.1073/pnas.0408962102 · 2005 · External reference

Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts

10.1016/j.jacc.2011.10.895 · 2012 · External reference

Parameter optimization for reproducible cardiac 1H-MR spectroscopy at 3 Tesla

10.1002/jmri.25254 · 2016 · External reference

Second-order motion compensated PRESS for cardiac spectroscopy

10.1002/mrm.26099 · 2016 · External reference

Cardiac carbon 13 magnetic resonance spectroscopy: on the horizon or over the rainbow?

10.1067/mnc.2002.125811 · 2002 · External reference

13C-NMR for the study of intermediary metabolism

10.1007/bf02660933 · 1998 · External reference

Hyperpolarized magnetic resonance a novel technique for the in vivo assessment of cardiovascular disease

10.1161/circulationaha.111.024919 · 2011 · External reference

Clinical implications of cardiac hyperpolarized magnetic resonance imaging

10.1186/1532-429x-15-93 · 2013 · External reference

On the present and future of dissolution-DNP

10.1016/j.jmr.2016.01.015 · 2016 · External reference

Hyperpolarized MRI - an update and future perspectives

10.1053/j.semnuclmed.2021.09.001 · 2022 · External reference

Real-Time assessment of krebs cycle metabolism with hyperpolarised [2-13c]pyruvate

10.1136/hrt.2009.191049c · 2010 · External reference

Investigating metabolic flux in the hyperthyroid heart using hyperpolarised magnetic resonance

10.1136/hrt.2009.191064c · 2010 · External reference

The cycling of acetyl-coenzyme A through acetylcarnitine buffers cardiac substrate supply: a hyperpolarized 13C magnetic resonance study

10.1161/circimaging.111.969451 · 2012 · External reference

Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease

10.1161/circulationaha.111.024919 · 2011 · External reference

Hyperpolarized 13C metabolic MRI of the human heart: initial experience

10.1161/circresaha.116.309769 · 2016 · External reference

Noninvasive in vivo assessment of cardiac metabolism in the healthy and diabetic human heart using hyperpolarized (13)C MRI

10.1161/circresaha.119.316260 · 2020 · External reference

Proof-of-Principle demonstration of direct metabolic imaging following myocardial infarction using hyperpolarized 13C CMR

10.1016/j.jcmg.2020.12.023 · 2021 · External reference

Navigator gating and volume tracking for double-triggered cardiac proton spectroscopy at 3 Tesla

10.1002/mrm.20123 · 2004 · External reference

Human cardiac 31P magnetic resonance spectroscopy at 7 tesla

10.1002/mrm.24922 · 2014 · External reference

Phosphorus (31P) magnetic resonance spectroscopy at 7 tesla in patients with dilated cardiomyopathy

10.1148/radiol.2016152629 · 2016 · External reference

Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T

10.1002/nbm.1350 · 2009 · External reference

Suppression of skeletal muscle signal using a crusher coil: a human cardiac 31p-MR spectroscopy study at 7 tesla

10.1002/mrm.25755 · 2016 · External reference

MR spectroscopy of the human heart: the status and the challenges

10.1148/radiology.191.3.8184033 · 1994 · External reference

Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy

10.1126/science.4023711 · 1985 · External reference

Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance

10.1002/mrm.1910140302 · 1990 · External reference

Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy

10.1002/mrm.1910350507 · 1996 · External reference

Compressed sensing to accelerate magnetic resonance spectroscopic imaging: evaluation and application to Na-23-imaging of mouse hearts

10.1186/s12968-015-0149-6 · 2015 · External reference

Dynamic (31) P-MRSI using spiral spectroscopic imaging can map mitochondrial capacity in muscles of the human calf during plantar flexion exercise at 7 T

10.1002/nbm.3662 · 2016 · External reference

Three-dimensional, 2.5-minute, 7 T phosphorus magnetic resonance spectroscopic imaging of the human heart using concentric rings

10.1002/nbm.4813 · 2023 · External reference

Investigating the effect of trigger delay on cardiac 31P-MRS signals

10.1038/s41598-021-87063-8 · 2021 · External reference

Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7 T (31)P-cardiovascular magnetic resonance spectroscopy

10.1186/s12968-019-0529-4 · 2019 · External reference

Quantifying the effect of dobutamine stress on myocardial Pi and pH in healthy volunteers: a (31) P MRS study at 7 T

10.1002/mrm.28494 · 2021 · External reference

Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla

10.1002/mrm.23011 · 2011 · External reference

A 3D hybrid-shot spiral sequence for hyperpolarized 13C imaging

10.1002/mrm.28462 · 2021 · External reference

Robust and high resolution hyperpolarized metabolic imaging of the rat heart at 7 T with 3D spectral-spatial EPI

10.1002/mrm.25730 · 2016 · External reference

Reduction of motion artifacts in cine MRI using variable-density spiral trajectories

10.1002/mrm.1910370416 · 1997 · External reference

Two repetition time saturation transfer (TwiST) with spill-over correction to measure creatine kinase reaction rates in human hearts

10.1186/s12968-015-0175-4 · 2015 · External reference

On neglecting chemical exchange effects when correcting in vivo P-31 MRS data for partial saturation

10.1006/jmre.2000.2166 · 2001 · External reference

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure

10.1161/01.cir.86.6.1810 · 1992 · External reference

Absolute concentrations of myocardial high-energy phosphate metabolites in normal, hypertrophied and failing human myocardium, measured non-invasively with 31P-SLOOP-magnetic resonance spectroscopy

10.1016/s0735-1097(02)02160-5 · 2002 · External reference

Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy [see comments]

10.1161/01.cir.92.1.15 · 1995 · External reference

Rapid, reliable in vivo assays of human phosphate metabolitesby nuclear magnetic resonance

1989 · External reference

Advances in human cardiac P-31-MR spectroscopy: SLOOP and clinical applications

10.1002/jmri.1074 · 2001 · External reference

Magnetic resonance spectroscopy with linear algebraic modeling (SLAM) for higher speed and sensitivity

10.1016/j.jmr.2012.03.008 · 2012 · External reference

Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding

10.1016/j.jmr.2013.09.018 · 2013 · External reference

Compartment-based reconstruction of 3D acquisition-weighted (31) P cardiac magnetic resonance spectroscopic imaging at 7 T: A reproducibility study

10.1002/nbm.4950 · 2023 · External reference

Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo

10.1002/mrm.10130 · 2002 · External reference

Quantitative Cardiac P-31 spectroscopy at 3 tesla using adiabatic pulses

10.1002/mrm.21867 · 2009 · External reference

31P NMR spectroscopy of human heart at 4 T: detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium

10.1002/mrm.1910260216 · 1992 · External reference

3D 31P spectroscopic imaging of the human heart at 4.1 T

10.1002/mrm.1910330318 · 1995 · External reference

A comparison of cardiac 31P MRS at 1.5 and 3 T

10.1002/nbm.1255 · 2008 · External reference

Unresolved reference

2010 · External reference

Navigator gating and volume tracking for double-triggered cardiac proton spectroscopy at 3 tesla

10.1002/mrm.20123 · 2004 · External reference

Reproducibility of human cardiac phosphorus MRS ((31) P-MRS) at 7 T

10.1002/nbm.4095 · 2019 · External reference

Adiabatic excitation for 31P MR spectroscopy in the human heart at 7 T: A feasibility study

10.1002/mrm.26576 · 2017 · External reference

Whole-body radiofrequency coil for (31) P MRSI at 7 T

10.1002/nbm.3517 · 2016 · External reference

Using a whole-body 31P birdcage transmit coil and 16-element receive array for human cardiac metabolic imaging at 7 T

10.1371/journal.pone.0187153 · 2017 · External reference

W(h)ither human cardiac and body magnetic resonance at ultrahigh fields? Technical advances, practical considerations, applications, and clinical opportunities

10.1002/nbm.3268 · 2015 · External reference

Clinical applications at ultrahigh field (7 T). Where does it make the difference?

10.1002/nbm.3272 · 2015 · External reference

Effect of the sporting discipline on the right and left ventricular morphology and function of elite male track runners: a magnetic resonance imaging and phosphorus 31 spectroscopy study

10.1016/j.ahj.2007.06.039 · 2007 · External reference

Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy

10.1093/oxfordjournals.eurheartj.a015046 · 1996 · External reference

Insights into the metabolic aspects of aortic stenosis with the use of magnetic resonance imaging

10.1016/j.jcmg.2022.04.025 · 2022 · External reference

Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy

10.1007/s00380-016-0844-8 · 2017 · External reference

Association between myocardial triglyceride content and cardiac function in healthy subjects and endurance athletes

10.1371/journal.pone.0061604 · 2013 · External reference

Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction

10.1161/circulationaha.119.043450 · 2020 · External reference

Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism

10.1161/01.cir.99.17.2261 · 1999 · External reference

Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium

10.1161/circulationaha.106.613646 · 2006 · External reference

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion

10.1016/s0168-9525(03)00081-7 · 2003 · External reference

Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy

10.1002/jmri.1880020616 · 1992 · External reference

31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging

10.1016/0002-8703(93)91002-v · 1993 · External reference

Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy

10.1016/s0002-9149(97)00456-6 · 1997 · External reference

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy

10.1016/s0735-1097(02)03009-7 · 2003 · External reference

P-31 magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: experiences at 3 T

10.1016/j.ejrad.2008.10.018 · 2010 · External reference

31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy

10.1161/01.cir.97.25.2536 · 1998 · External reference

Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy

10.1161/01.cir.101.12.e121 · 2000 · External reference

Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy

10.1016/j.amjcard.2013.05.017 · 2013 · External reference

Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction

10.1093/eurheartj/ehv120 · 2015 · External reference

Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy

10.1016/j.jacc.2003.05.005 · 2003 · External reference

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy

10.1161/circulationaha.109.934059 · 2010 · External reference

Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans

10.1161/01.cir.97.17.1716 · 1998 · External reference

Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy

10.1016/s0735-1097(02)02160-5 · 2002 · External reference

Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function

10.1148/radiology.219.3.r01jn25637 · 2001 · External reference

Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy

10.1016/0140-6736(91)91838-l · 1991 · External reference

Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy

10.1177/108155899704500810 · 1997 · External reference

Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction

10.1186/1532-429x-16-29 · 2014 · External reference

Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis

10.1161/circulationaha.122.063444 · 2023 · External reference

Role of cardiac energetics in aortic stenosis disease progression: identifying the high-risk metabolic phenotype

10.1161/circimaging.122.014863 · 2023 · External reference

Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis

10.1161/circimaging.113.000559 · 2013 · External reference

A randomised double-blind placebo-controlled study of fenofibrate as a metabolic modulator to augment cardiac physiology in moderate-severe aortic stenosis

2023 · External reference

Effects of catecholamine stress on diastolic function and myocardial energetics in obesity

10.1161/circulationaha.111.069518 · 2012 · External reference

Cardiac adaptations to acute hemodynamic stress in function, perfusion, and energetics in Type 2 diabetes with overweight and obesity

10.2337/dc22-0887 · 2022 · External reference

Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes

10.2337/db15-0627 · 2016 · External reference

Reply: ectopic fat deposition and diabetes mellitus

10.1016/j.jacc.2016.09.939 · 2016 · External reference

Myocardial energetics in obesity: enhanced ATP delivery through creatine kinase with blunted stress response

10.1161/circulationaha.119.042770 · 2020 · External reference

Effects of weight loss on myocardial energetics and diastolic function in obesity

10.1007/s10554-012-0174-6 · 2013 · External reference

Obesity modifies the energetic phenotype of dilated cardiomyopathy

2021 · External reference

Empagliflozin treatment is associated with improvements in cardiac energetics and function and reductions in myocardial cellular volume in patients with type 2 diabetes

10.2337/db21-0270 · 2021 · External reference

Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart

10.1096/fj.04-2263com · 2004 · External reference

Evidence of a direct effect of myocardial steatosis on LV hypertrophy and diastolic dysfunction in adult and adolescent obesity

10.1016/j.jcmg.2014.12.019 · 2015 · External reference

Very low calorie diets are associated with transient ventricular impairment before reversal of diastolic dysfunction in obesity

10.1038/s41366-018-0263-2 · 2019 · External reference

Intravenous lipid infusion results in myocardial lipid droplet accumulation combined with reduced myocardial performance in heparinized rabbits

10.1111/j.1748-1716.1995.tb09847.x · 1995 · External reference

Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain fatty acid uptake and de novo fatty acid synthesis

10.1155/2012/205648 · 2012 · External reference

Very-low-calorie diet increases myocardial triglyceride content and decreases diastolic left ventricular function in type 2 diabetes with cardiac complications

10.2337/dc13-1423 · 2014 · External reference

Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death

10.1126/scitranslmed.3007328 · 2013 · External reference

Is cardiac failure a consequence of decreased energy reserve?

1993 · External reference

The creatine kinase system in normal and diseased human myocardium

10.1056/nejm198510243131704 · 1985 · External reference

Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease

10.1093/eurheartj/16.suppl_o.115 · 1995 · External reference

Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy

10.1161/01.cir.96.7.2190 · 1997 · External reference

Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging

10.1007/s00330-004-2504-0 · 2005 · External reference

Cardiac energetics in patients with chronic heart failure and iron deficiency: an in-vivo (31) P magnetic resonance spectroscopy study

10.1002/ejhf.2454 · 2022 · External reference

Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction

10.1161/circulationaha.121.054858 · 2021 · External reference

The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study

10.1186/s12968-018-0511-6 · 2018 · External reference

Triple repetition time saturation transfer (TRiST) (31)P spectroscopy for measuring human creatine kinase reaction kinetics

10.1002/mrm.22347 · 2010 · External reference

Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved

10.1172/jci57426 · 2012 · External reference

Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy

10.1016/j.jchf.2014.09.009 · 2015 · External reference

Retained metabolic flexibility of the failing human heart

10.1161/circulationaha.122.062166 · 2023 · External reference

Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure

10.1093/eurheartj/ehi816 · 2006 · External reference

Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure

10.1186/s12968-016-0228-3 · 2016 · External reference

Left ventricular function and myocardial triglyceride content on 3 T Cardiac MR predict major cardiovascular adverse events and readmission in patients hospitalized with acute heart failure

10.3390/jcm9010169 · 2020 · External reference

Usefulness of 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study

10.1016/s1076-6332(03)00104-1 · 2003 · External reference

Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine

10.1016/j.cardfail.2010.05.006 · 2010 · External reference

Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial

10.1161/circulationaha.122.062021 · 2023 · External reference

TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study

10.1007/s12471-020-01407-z · 2020 · External reference

Effects of the novel long-acting GLP-1 Agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction

10.1016/j.jchf.2016.01.008 · 2016 · External reference

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy

10.1136/heartjnl-2022-322271 · 2023 · External reference

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

2025 · External reference

DIABETES PDH FED In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance

10.1073/pnas.0805953105 · 2008 · External reference

Metabolic imaging of acute and chronic infarction in the perfused rat heart using hyperpolarised [1‐13C] pyruvate

10.1002/nbm.2972 · 2013 · External reference

Hyperpolarized metabolic MR imaging of acute myocardial changes and recovery after ischemia-reperfusion in a small-animal model

10.1148/radiol.2015151332 · 2015 · External reference

Cardiac energetics in severe mitral regurgitation: relationship with eccentric hypertrophy, stroke volume, and effects of valve repair

2025 · External reference

Contribution of various substrates to total citric acid cycle flux and anaplerosis as determined by 13C isotopomer analysis and O2 consumption in the heart

10.1007/bf01759778 · 1996 · External reference